[57] The activation of central neuronal GLP-1 receptors by semaglutide signals through the endogenous opioid and adrenergic systems to suppress peripheral inflammation
Foxo4dri is a senolytic peptide that disrupts the p53 gene, causing apoptosis in ageing cells
avoid diuretics | | Oral bisphosphonates (alendronate) | Gastric emptying delay may reduce already-low bioavailability | Efficacy loss possible | Minor | Take bisphosphonate on empty stomach 30 min before triple agonist | Prescribing Framework for Triple Agonists No FDA-approved labeling for retatrutide existed as of July 2025, but phase 2 and phase 3 trial protocols establish a de facto dosing framework that clinicians in early-access or clinical-trial settings follow
Inflammation can cause damage to healthy cells, tissues and organs, and may cause internal scarring, tissue death and damage to the DNA in previously healthy cells, in addition to being linked to chronic illnesses like cardiovascular disease, cancer, Alzheimer's disease, obesity, diabetes